About this trial
The study aims to test if autofluorescence imaging (AF) is a useful surgical aid during parathyroidectomy (PTX) for primary hyperthyroidism (PHPT).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age>18 years and able to give informed consent.
A diagnosis of PHPT.
Planned exploratory PTX with ioPTH measurement.
Disqualifiers
Concordant high-confidence imaging; planned focused/selective PTX
Previous thyroid or parathyroid surgery.
Planned simultaneous thyroid surgery.
MEN, lithium induced hyperparathyroidism.
Trial design
Parallel
Treatments tested in this trial
Surgery with autofluorescence
Procedure/SurgeryIn the experimental group, the surgeon will use the EleVision IR camera system (Medtronic, USA) to visualize PTGs during surgery. The surgical field will be visualized with AF as a minimum of two times during surgery on each side of the neck: First upon exposing the undersurface of the thyroid gland, and secondly before removal of a pathological PTG. Also, removed PTGs will be examined ex vivo to document AF pattern.
Treatment groups
Trial outcomes
Primary outcomes
Operating time
Time elapsed from skin incision to skin closure in patients who achieve normocalcemia after one operation.
Secondary outcomes
Normocalcemia
Proportion of patients with normocalcemia after 2 months after only one surgical procedure without treatment with active vitamin D or \>1g calcium daily.
Extent of surgery
Proportion of patients having thyroidectomy or thymectomy to eradicate parathyroid tissue
Number of ioPTH measurements
Number of ioPTH measurements
ioPTH reduction
Relative PTH reduction (first to last measurement).
Sponsors and contacts
Click on the lead sponsor to view all of their trials.